NASBS News and Upcoming Events

Vol 11 No 1 Archive

Annual Meeting - Call for Abstracts

ABSTRACT CONTENT
1. The title should be in upper and lower case letters along and inside the top of the box space in which the abstract is typed. If possible, the title should be in bold type. Preferred font is 12 point Times Roman. Author information should not listed here, but listed in the section of this form requesting presenting and co-author information. 2. Adequately describe the objectives of the study so that the quality of the work can be evaluated by the Program Committee. 3. The abstract should contain an introduction presenting the purpose of the study, a brief description of the procedures employed, a summary of the results and a statement of the conclusions. 4. The abstract should be approximately 150 words in English.

SUBMIT YOUR ABSTRACT
The Program Committee STRONGLY REQUESTS THAT ABSTRACTS BE SUBMITTED BY E-MAIL. The abstract and all the information on the form may be e-mailed as an attachment (Word or Word Perfect format, any version), or pasted into an e-mail message as generic text. If the abstract contains tables or complicated symbols, it should be sent as an attachment. To submit the abstract by e-mail, present the information requested in this order:

• Presenting author address & co-author information
• Title of abstract
• Abstract
• Presentation preference
• Answers to disclosure of commercial relationship questions

E-MAIL THE ABSTRACT TO:
elucini@drohanmgmt.com
Acknowledgement of receipt will be e-mailed within 24 hours.

OR.....MAIL COMPLETED ABSTRACT FORM AND SIX COPIES TO:
North American Skull Base Society
4815 Rugby Avenue, Suite 203
Bethesda, Maryland 20814

OR.....between Sep. 25 and Oct. 1, you may FAX the completed abstract form (front & back) to:
NASBS FAX: 301-718-8692
then, mail the original form and six copies to the NASBS.

******************************************************* *******************************************************

PRESENTING AUTHOR & CO-AUTHOR INFORMATION:

Presenting Author & Degree:
Address (Department):
Address (Institution):
Address (Street, Suite, Box):
City, State, Postal Code, Country:
Phone:
FAX:
E-mail Address:
Co-Author (Full name and degree only):
Co-Author (Full name and degree only):
Co-Author (Full name and degree only):
Co-Author (Full name and degree only):

*******************************************************

TITLE OF ABSTRACT:

*******************************************************

ABSTRACT:

*******************************************************

PRESENTATION PREFERENCE:
Please consider this abstract to be presented in the following format at the Annual Meeting: (Check one only)
[ ] Oral Presentation Only
[ ] Poster Presentation Only
[ ] Oral OR Poster Presentation (at discretion of Program Com.)

*******************************************************

DISCLOSURE OF COMMERCIAL RELATIONSHIPS:
The North American Skull Base Society must insure balance, independence, objectivity, and scientific rigor in all its individually sponsored or jointly sponsored educational activities. All faculty participating in a sponsored activity are expected to disclose to the activity audience any significant financial interest or other relationship (1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity (significant financial interest or other relationship can include such things as grants or research support, employee, consultant, major stock holder, member of speakers bureau, etc). The intent of this disclosure is not to prevent a speaker with a significant financial or other relationship from making a presentation, but rather to provide listeners with information on which they can make their own judgments. It remains for the audience to determine whether the speaker's interests or relationships may influence the presentation with regard to exposition or conclusion.

Presenter:
Title of Presentation:
Please Complete Both Sections I. and II.
Section I.
a. Will your presentation include discussion of any commercial products or services?
[ ] Yes [ ] No
b. If Yes, do you have a significant financial interest or other relationship with the manufacturer(s) of any of the products or provider(s) of any of the services you intend to discuss?
[ ] Yes [ ] No
If Yes, please list the manufacturer(s) or provider(s) and describe the nature of the relationship(s),

Section II.
Do you have a significant relationship(s) with ANY commercial entities that relate to your presentation?
[ ] Yes [ ] No
If Yes, please list the relevant commercial supporter(s) and describe the nature of the relationship(s).

Signature (Submitted by):

Date:

INSTRUCTIONS FOR ELECTRONIC SUBMISSION OF ABSTRACT

The Program Committee STRONGLY REQUESTS THAT ABSTRACTS BE SUBMITTED BY E-MAIL.

Please observe the following guidelines.
1. Submit only ONE abstract per e-mail message.
2. The abstract and all the information on the form may be e-mailed as an attachment (Word® or Word Perfect® format, any version), or pasted into an e-mail message as generic text.
3. Avoid the use of templates and macros when preparing the abstract, and submitting the abstract as an attachment. Minimize superfluous formatting codes. Keep the abstract format as simple as possible.
4. If the abstract contains tables or complicated symbols, it should be sent as an attachment.
5. Use left justification the abstract. Do not use center justification.
6. Follow the sequence shown below for submitting the abstract and required information.
   

   EXAMPLE OF PREFERRED FORMAT FOR ELECTRONIC SUBMISSION
   

   Presenting Author:
   Franco DeMonte, MD
   Department of Neurosurgery
   MD Anderson Cancer Center
   Houston, Texas 77401
   Tel: 713-792-2400
   Fax: 713-794-4950
   E-Mail: fdemonte@mdanderson.org
   

   Co-authors:
   Yashail Y. Vora, MD, Edguardo Diaz, MD, Jeffrey N. Myers, MD, Dima Abi-Said, MD
   

   Title:
   Anterolateral Skull Base Tumors
   

   Abstract:
   

   Introduction: Neoplasms involving the anterolateral skull base are rare. We describe our experience at a major cancer referral center.
   

   Methods and Materials: Records of patients since 1992, presenting with neoplasms involving the base of the skull bounded medially by sphenoid sinus, anteriorly by the sphenoid wings, and laterally by petrous internal carotid artery, were retrospectively reviewed.
   

   Results: The median age of 28 patients was 47 years. Sarcomas were the most common tumors (46%). Squamous-cell carcinomas, chordomas and atypical/anaplastic meningiomas totaled 36%. Spread to the dura, brain or along perineural space occurred in 43%. Patients frequently required multiple surgeries (60%), chemotherapy (71%) and radiotherapy (61%). Median follow-up spanned 3.8 years. Median time to recurrence was 18.9 months with 36% of the patients being alive without cancer and 32% with cancer while 21% of patients had died from cancer. 2 patients were lost to follow-up and 1 patient died of pulmonary embolism. The 1-year and 5-year survivals were 88% and 63% respectively.
   

   Conclusion: Anterolateral skull base tumor management is challenging. Tumor control and a useful survival benefit can be achieved in most patients.
   

   Presentation Preference:
   Oral presentation only
   

   Disclosure of Commercial Relationships:
   I. no
   II. no
   

   Submitted by:
   Franco DeMonte, MD
   

   
   

   ---